Cedarburg Hauser Granted DEA Registration for Denver Manufacturing Facility
Denver, CO (February 27, 2013) – Cedarburg Hauser Pharmaceuticals (CHP), a contract development and manufacturing organization (CDMO), announced today that its Denver, Colorado facility has been granted registration as a manufacturer of schedule II-V controlled substances by the U.S Drug Enforcement Agency (DEA). The new DEA registration status is the result of a concerted effort [...]
Continue Reading →Posted in: News
Leave a Comment: (0) →